TNFA (tnfpharma.com) Future Price to Earnings

Official company branding of TNF Pharmaceuticals, Inc. (TNFA)

TNF Pharmaceuticals develops cutting-edge anti-inflammatory treatments and systemic body rejuvenation therapies. The company's estimated forward P/E helps identify stock value reversal points relative to earnings, with 0.00 recorded as the baseline value. The business aims to expand its drug portfolio and capture market niches. Currently, the priority has shifted toward validating molecules through partnerships rather than mergers.

TNF Pharmaceuticals - TNFA Market Cap to Future Earnings Ratio (period 07/25/2024 - 09/25/2025)

Summary analytical data breakdowns for tnfpharma.com (TNFA)

- current price and projected stock value:
Fundamental valuation:TNF Pharmaceuticals, Inc. TNFA
Brand item of TNF Pharmaceuticals

While catalysts for new clinical phases of the TNF Pharmaceuticals pipeline remain uncertain, the market is relying on expected net income to calculate business value. A forward P/E valuation of TNF Pharmaceuticals compares current market capitalization with projected earnings, allowing investors to use this chart to determine whether the current price represents an undervalued asset or the beginning of a long-term impairment of the enterprise's fundamental value.

Key competitors

Future Price to Earnings haleon.com (HLN)|KVUE (Kenvue Health) - Future Price to Earnings Multiple|Future Price to Earnings Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Projected Price to Earnings Ratio|LGND: Projected Price to Earnings|Amneal - Market Cap to Future Earnings Ratio|PRGO: Forward P/E Multiple|Alvotech Corp - Future Price to Earnings Multiple|LQDA (Liquidia Corp) - Forward P/E Multiple|Projected Price to Earnings Ratio glpg.com GLPG|Future Price to Earnings ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Future Price to Earnings Multiple|Forward P/E Multiple AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Price to Expected Earnings Ratio|SPRY - Future Price to Earnings|Future Price to Earnings Multiple TBPH (Theravance Biopharma)|AQST (aquestive.com) - Projected Price to Earnings|Price to Expected Earnings Ratio SCPH (scPharmaceuticals, Inc.)|Projected Price to Earnings TECX|Tonix Pharmaceuticals (TNXP) - Market Cap to Projected Earnings|Forward P/E Multiple SXTC|Forward P/E Multiple Eupraxia Pharma (EPRX)|Future Price to Earnings BioHarvest Sciences Inc. BHST|EXOZ - Projected Price to Earnings|ORMP: Projected Price to Earnings|Future Price to Earnings Multiple ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Future Price to Earnings|Projected Price to Earnings Ratio abvcpharma.com (ABVC)|Future Price to Earnings Cumberland Pharma|Future Price to Earnings QNTM|Forward P/E Multiple FGEN|TELO (Telomir Pharma) - Future Price to Earnings Multiple|Future Price to Earnings Rani Therapeutics Holdings RANI|SNYR - Projected Price to Earnings|RLYB - Future Price to Earnings|Market Cap to Projected Earnings lexariabioscience.com LEXX|PULM: Forward P/E Multiple|Price to Future Earnings Ratio PTHL|Future Price to Earnings Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc.) - Market Cap to Future Earnings Ratio|Forward P/E Multiple IBO|YCBD: Price to Expected Earnings Ratio|Future Price to Earnings PainReform PRFX|altamiratherapeutics.com (CYTO) - Projected Price to Earnings Ratio|LIPO: Projected Price to Earnings|OPTN (optinose.com) - Price to Future Earnings Ratio|PIRS: Forward P/E Multiple|PROC - Market Cap to Projected Earnings|PTPI (Petros Pharma) - Forward P/E Multiple|Future Price to Earnings QLI|Forward P/E Multiple SLRN|Market Cap to Future Earnings Ratio TFFP